207 related articles for article (PubMed ID: 19061356)
1. Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage.
Gazzeri R; Galarza M; Neroni M; Alfieri A; Esposito S
J Neurosurg; 2009 May; 110(5):939-42. PubMed ID: 19061356
[TBL] [Abstract][Full Text] [Related]
2. Local hemostatic matrix for endoscope-assisted removal of intracerebral hemorrhage is safe and effective.
Luh HT; Huang AP; Yang SH; Chen CM; Cho DY; Chen CC; Kuo LT; Li CH; Wang KC; Tseng WL; Hsing MT; Yang BS; Lai DM; Tsai JC
J Formos Med Assoc; 2018 Jan; 117(1):63-70. PubMed ID: 28343893
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.
Gazzeri R; Galarza M; Neroni M; Alfieri A; Giordano M
Acta Neurochir (Wien); 2011 Jan; 153(1):148-54; discussion 155. PubMed ID: 20703888
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma.
Angioli R; Muzii L; Montera R; Damiani P; Bellati F; Plotti F; Zullo MA; Oronzi I; Terranova C; Panici PB
J Minim Invasive Gynecol; 2009; 16(2):153-6. PubMed ID: 19138574
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic gelatine-thrombin matrix (Floseal®) facilitates hemostasis and organ preservation in laparoscopic treatment of tubal pregnancy.
Watrowski R
Arch Gynecol Obstet; 2014 Sep; 290(3):411-5. PubMed ID: 24816598
[TBL] [Abstract][Full Text] [Related]
8. Gelatin-thrombin hemostatic matrix in the management of placental site postpartum hemorrhage: a case report.
Wohlmuth CT; Dela Merced J
J Reprod Med; 2011; 56(5-6):271-3. PubMed ID: 21682125
[TBL] [Abstract][Full Text] [Related]
9. Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix.
Pursifull NF; Morris MS; Harris RA; Morey AF
J Trauma; 2006 Feb; 60(2):346-50. PubMed ID: 16508494
[TBL] [Abstract][Full Text] [Related]
10. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.
Ellegala DB; Maartens NF; Laws ER
Neurosurgery; 2002 Aug; 51(2):513-5; discussion 515-6. PubMed ID: 12182794
[TBL] [Abstract][Full Text] [Related]
11. Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study.
Durrani OM; Fernando AI; Reuser TQ
Ophthalmic Plast Reconstr Surg; 2007; 23(1):25-7. PubMed ID: 17237685
[TBL] [Abstract][Full Text] [Related]
12. FloSeal Matrix: new generation topical hemostatic sealant.
Oz MC; Rondinone JF; Shargill NS
J Card Surg; 2003; 18(6):486-93. PubMed ID: 14992097
[No Abstract] [Full Text] [Related]
13. Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin based agent (FloSeal).
Baumann A; Caversaccio M
Rhinology; 2003 Dec; 41(4):244-9. PubMed ID: 14750353
[TBL] [Abstract][Full Text] [Related]
14. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group.
Oz MC; Cosgrove DM; Badduke BR; Hill JD; Flannery MR; Palumbo R; Topic N
Ann Thorac Surg; 2000 May; 69(5):1376-82. PubMed ID: 10881808
[TBL] [Abstract][Full Text] [Related]
15. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
Gazzeri R; Galarza M; Alfier A
Surg Technol Int; 2012 Dec; 22():49-54. PubMed ID: 22915500
[TBL] [Abstract][Full Text] [Related]
16. Surgical Management of Supratentorial Intracerebral Hemorrhages: Endoscopic Versus Open Surgery.
Eroglu U; Kahilogullari G; Dogan I; Yakar F; Al-Beyati ESM; Ozgural O; Cohen-Gadol AA; Ugur HC
World Neurosurg; 2018 Jun; 114():e60-e65. PubMed ID: 29567287
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic matrix application after open synovectomy in a hemophilic patient.
García Aríz M; Pérez-Carrasquillo O; Zierenberg CE; Cheleuitte J; Guerra JA; Santiago-Borrero PJ
Am J Orthop (Belle Mead NJ); 2012 Apr; 41(4):179-81. PubMed ID: 22530221
[TBL] [Abstract][Full Text] [Related]
18. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery.
Weaver FA; Hood DB; Zatina M; Messina L; Badduke B
Ann Vasc Surg; 2002 May; 16(3):286-93. PubMed ID: 11957004
[TBL] [Abstract][Full Text] [Related]
19. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.
Fiss I; Danne M; Stendel R
Neurol Med Chir (Tokyo); 2007 Oct; 47(10):462-7. PubMed ID: 17965563
[TBL] [Abstract][Full Text] [Related]
20. A Gelatin-Thrombin Matrix Topical Hemostatic Agent (Floseal) in Combination With Harmonic Scalpel Is Effective in Patients Undergoing Total Thyroidectomy: A Prospective, Multicenter, Single-Blind, Randomized Controlled Trial.
Docimo G; Tolone S; Conzo G; Limongelli P; Del Genio G; Parmeggiani D; De Palma M; Lupone G; Avenia N; Lucchini R; Monacelli M; Gulotta G; Scerrino G; Pasquali D; Bellastella G; Esposito K; De Bellis A; Pezzolla A; Ruggiero R; Docimo L
Surg Innov; 2016 Feb; 23(1):23-9. PubMed ID: 26243629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
